| Bioactivity | Antitumor agent-183 (compound 3f) has antitumor activity with metabolic stability. Antitumor agent-183 inhibits cancer cell growth, with IC50s less than 5 nM for A549, HCT116, and HS578T cells. The albumin-bound nanoparticle formulation of Antitumor agent-183 has prolonged retention in the tumor tissues[1]. |
| CAS | 2775428-94-7 |
| Formula | C31H18D15BrN4O9 |
| Molar Mass | 700.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yu W, et al. Deuterium Editing of Small Molecules: A Case Study on Antitumor Activity of 1,4-Benzodiazepine-2,5-dione Derivatives. J Med Chem. 2024 Jul 18. |
Antitumor agent-183
CAS: 2775428-94-7 F: C31H18D15BrN4O9 W: 700.61
Antitumor agent-183 (compound 3f) has antitumor activity with metabolic stability.Antitumor agent-183 inhibits cancer ce
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.